Orca Pharmaceuticals is a company that develops oral drugs for the treatment of chronic inflammatory disease. Its medicinal chemistry program produces orally available inhibitors of RORγ, a nuclear hormone receptor found in a class of white blood cells involved in autoimmune disease.